At the 77th WHA, member states are deliberating over a resolution to ‘Accelerate progress towards reducing maternal, newborn, and child mortality in order to achieve SDG targets 3.1 and 3.2.’ This resolution states that ’63 countries will miss the neonatal mortality target, and 54 countries will miss the under-five mortality target by 2030′. One of the contributing factors is the slow development of paediatric medicines which continues to lag unacceptably behind that of adults by nearly a decade.
GAP-f, the Global Accelerator for Paediatric Formulations, with partners DNDi, EGPAF, MMV, and MPP, are convening a dialogue among key stakeholders about how to strengthen and sustain political attention and accountability at the multilateral regional and national levels on innovation and access to essential medicines for children.
Side event
Date: Wednesday, 29 May 2024
Time: 12:30-14:00
Venue: ICRC Museum, Geneva
